Allworth Financial’s Amgen AMGN Stock Holding History

Allworth Financial’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold	0	–	-$28.2K	–	5018
2025 Q3	–	Hold	0	–	–	–	2495

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allworth Financial's AMGN Position: Q2 2026 in Review

Allworth Financial reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $238K and leaving 53,858 shares worth $19.5M. The position accounts for 0.08% of the portfolio, ranked #154.

Allworth Financial first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Allworth Financial held 53,858 shares of Amgen worth $19.5M as of Q2 2026.
Allworth Financial sold 696 Amgen shares in Q2 2026, an estimated $238K.
Amgen made up 0.08% of Allworth Financial's portfolio in Q2 2026, its #154 holding.
Allworth Financial first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.